SOD1 and breast cancer: The results showed that compared to the BC group, the ox-LDL group exhibited a dramatic increase in MDA levels and a decrease in intracellular SOD enzyme activity; this increase in MDA levels was reversed by treatment with both NHJ and SHJ, with the effect increasing as the NHJ or SHJ dose increased.